Reilly Financial Advisors’s Histogen Inc. Common Stock HSTO Stock Holding History

Reilly Financial Advisors’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-110	Closed	-$3K	–	1106
2021 Q1	$3K	Hold	110	–	–	﹤0.01%	894
2020 Q4	$2K	Hold	110	–	–	﹤0.01%	834
2020 Q3	$4K	Hold	110	–	–	﹤0.01%	701
2020 Q2	$8K	Hold	110	–	–	﹤0.01%	647
2020 Q1	$7K	Hold	110	–	–	﹤0.01%	631
2019 Q4	$9K	Hold	110	–	–	﹤0.01%	657
2019 Q3	$7K	Hold	110	–	–	﹤0.01%	701
2019 Q2	$6K	Hold	110	–	–	﹤0.01%	761
2019 Q1	$24K	Hold	110	–	–	﹤0.01%	492
2018 Q4	$38K	Hold	110	–	–	0.01%	376
2018 Q3	$128K	Hold	110	–	–	0.02%	216
2018 Q2	$94K	Hold	110	–	–	0.01%	228
2018 Q1	$129K	Hold	110	–	–	0.02%	193
2017 Q4	$102K	Hold	110	–	–	0.01%	231
2017 Q3	$121K	Hold	110	–	–	0.02%	194
2017 Q2	$127K	Hold	110	–	–	0.02%	188
2017 Q1	$127K	Hold	110	–	–	0.02%	177
2016 Q4	$116K	Sell	110 -50	-31%	-$22.7K	0.02%	180
2016 Q3	$64K	Hold	160	–	–	0.01%	244
2016 Q2	$66K	Hold	160	–	–	0.01%	233
2016 Q1	$69K	Hold	160	–	–	0.01%	329
2015 Q4	$92K	Hold	160	–	–	0.02%	285
2015 Q3	$142K	Hold	160	–	–	0.03%	208
2015 Q2	$165K	Buy	+160	New	+$188K	0.03%	208

Other funds holding HSTO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Reilly Financial Advisors's HSTO Position: Q2 2021 in Review

Reilly Financial Advisors sold out of Histogen Inc. Common Stock (HSTO) in Q2 2021, closing a stake of 110 shares — an estimated $3K sold.

Reilly Financial Advisors first reported a position in HSTO in Q2 2015 and held it in 24 quarters. The position peaked at $165K in Q2 2015. 24 funds tracked by Wall St. Rank hold HSTO as of Q2 2021.

Reilly Financial Advisors reported no remaining Histogen Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Reilly Financial Advisors sold 110 Histogen Inc. Common Stock shares in Q2 2021, an estimated $3K.
Reilly Financial Advisors first reported a position in Histogen Inc. Common Stock in Q2 2015 and held it in 24 quarters.
Reilly Financial Advisors's Histogen Inc. Common Stock position peaked at $165K in Q2 2015.
24 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2021.

Based on Reilly Financial Advisors's 13F filing for Q2 2021, filed 3 Aug 2021.